Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / KRBP - Dr. Leonardo Mirandola is the new Chief Scientific Officer of Kiromic biopharma

KRBP - Dr. Leonardo Mirandola is the new Chief Scientific Officer of Kiromic biopharma

Kiromic BioPharma Inc.
  • Kiromic BioPharma ( NASDAQ: KRBP ) appoints Leonardo Mirandola, Ph.D., as Chief Scientific Officer, effective immediately.
  • Dr. Mirandola has served as the Company’s Vice President of R&D and Clinical Translation since September 2021 and his previous role was Head of Clinical Translation from 2020 to 2021.
  • He joined the company in 2016 as Executive Director of R&D.

For further details see:

Dr. Leonardo Mirandola is the new Chief Scientific Officer of Kiromic biopharma
Stock Information
Company Name: Kiromic BioPharma Inc.
Stock Symbol: KRBP
Market: NASDAQ
Website: kiromic.com
Menu
KRBP KRBP Quote KRBP Short KRBP News KRBP Articles KRBP Message Board
Get KRBP Alerts

News, Short Squeeze, Breakout and More Instantly...